Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PTGER2 | P43116 | 5/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 4/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | PTGFR | P43088 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28176629 | 0.95 | SMN1; SMN2 (0.37) | FFAR4FFAR1ALDH1A1PTGER2PTGER4 | |
| SCHEMBL16790832 | 0.85 | SMN1; SMN2 (0.40) | ALDH1A1CYP2D6LMNA | |
| SCHEMBL207971 | 0.85 | FFAR4 (0.35) | FFAR4FFAR1ALDH1A1PTGER2PTGER4 | |
| SCHEMBL14525068 | 0.82 | SMN1; SMN2 (0.35) | ALDH1A1CYP2D6LMNA | |
| SCHEMBL846324 | 0.81 | NAAA (0.43) | ALDH1A1LMNA | |
| SCHEMBL15686226 | 0.80 | SMN1; SMN2 (0.40) | ALDH1A1CYP2D6LMNA | |
| SCHEMBL1614689 | 0.80 | CYP2D6 (0.33) | CYP2D6LMNA | |
| SCHEMBL27261571 | 0.79 | SMN1; SMN2 (0.43) | LMNA | |
| SCHEMBL727614 | 0.78 | SMN1; SMN2 (0.34) | FFAR4FFAR1ALDH1A1PTGER2PTGER4 | |
| SCHEMBL10056797 | 0.78 | CYP2D6 (0.36) | ALDH1A1CYP2D6LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 228 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12214067-B2 | Oil-in-water emulsion sunscreen composition | ISP INVESTMENTS INC. (US) | 2025-02-04 | — | — | US | claimed |
| US-20220387290-A1 | SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-12-08 | — | — | US | claimed |
| US-20220125701-A1 | SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2022-04-28 | — | — | US | claimed |
| EP-3946642-A1 | SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2022-02-09 | — | — | EP | claimed |
| US-20210338539-A1 | LAMELLAR GEL BASED PERSONAL CARE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC | 2021-11-04 | — | — | US | claimed |
| EP-3099284-B1 | OIL-IN-WATER EMULSION SUNSCREEN COMPOSITION | ISP INVESTMENTS LLC (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020168336-A1 | SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2020-08-20 | — | — | WO | claimed |
| EP-3307395-B1 | SOLUBILISING AGENTS FOR UV SCREENING COMPOUNDS | ISP INVESTMENTS LLC (US) | 2020-08-05 | — | — | EP | claimed |
| EP-3600224-A1 | SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2020-02-05 | — | — | EP | claimed |
| US-10328003-B2 | Solubilizing agents for active or functional organic compounds | ISP INVESTMENTS LLC (US) | 2019-06-25 | — | — | US | claimed |
| EP-3307395-A1 | SOLUBILIZING AGENTS FOR FUNCTIONAL ACTIVE COMPOUNDS | ISP Investments LLC (US) | 2018-04-18 | — | — | EP | claimed |
| US-20170165187-A1 | OIL-IN -WATER EMULSION SUNSCREEN COMPOSITION | ISP INVESTMENTS INC. (US) | 2017-06-15 | — | — | US | claimed |
| WO-2016201260-A1 | SOLUBILIZING AGENTS FOR FUNCTIONAL ACTIVE COMPOUNDS | ISP INVESTMENTS INC. (US) | 2016-12-15 | — | — | WO | claimed |
| EP-3099284-A1 | OIL-IN-WATER EMULSION SUNSCREEN COMPOSITION | ISP Investments Inc. (US) | 2016-12-07 | — | — | EP | claimed |
| EP-3092272-A1 | COMPATIBILIZED COMPOSITIONS, ARTICLES FORMED THEREFROM, AND METHODS OF MANUFACTURE THEREOF | SABIC Global Technologies B.V. (NL) | 2016-11-16 | — | — | EP | claimed |
| WO-2015116899-A1 | OIL-IN -WATER EMULSION SUNSCREEN COMPOSITION | ISP INVESTMENTS INC. (US) | 2015-08-06 | — | — | WO | claimed |
| WO-2015106208-A1 | COMPATIBILIZED COMPOSITIONS, ARTICLES FORMED THEREFROM, AND METHODS OF MANUFACTURE THEREOF | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-07-16 | — | — | WO | claimed |
| US-8673272-B2 | Ultraviolet-absorbing compounds | ISP INVESTMENTS INC. (US) | 2014-03-18 | — | — | US | claimed |
| CN-102356121-A | Uv and light protective film | HUHTAMAKI FORCHHEIM | 2012-02-15 | — | — | CN | claimed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | UFM1, UHRF1, CUTA | FFAR4 3189/4885FFAR1 1680/4885ALDH1A1 152/4885 |
| US-10328003-B2 | Solubilizing agents for active or functional organic compounds | C1S, POLR1C, TYR | FFAR4 3294/4885FFAR1 2191/4885ALDH1A1 1257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.